IRadimed Corporation
IRMD
$96.84
$0.080.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.69% | 13.84% | 10.87% | 11.10% | 11.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.69% | 13.84% | 10.87% | 11.10% | 11.04% |
| Cost of Revenue | 13.87% | 13.65% | 10.86% | 14.58% | 12.73% |
| Gross Profit | 16.22% | 13.89% | 10.87% | 10.05% | 10.55% |
| SG&A Expenses | 15.76% | 9.33% | 12.38% | 10.35% | 19.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.61% | 10.73% | 9.57% | 10.55% | 18.28% |
| Operating Income | 18.05% | 20.63% | 14.39% | 12.41% | -1.97% |
| Income Before Tax | 13.70% | 16.87% | 13.39% | 11.67% | 0.15% |
| Income Tax Expenses | 25.74% | 13.55% | 13.64% | 4.87% | 2.04% |
| Earnings from Continuing Operations | 10.44% | 17.81% | 13.32% | 13.37% | -0.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.44% | 17.81% | 13.32% | 13.37% | -0.35% |
| EBIT | 18.05% | 20.63% | 14.39% | 12.41% | -1.97% |
| EBITDA | 20.56% | 20.07% | 13.09% | 11.74% | -1.78% |
| EPS Basic | 10.01% | 17.34% | 12.86% | 12.82% | -0.90% |
| Normalized Basic EPS | 13.27% | 16.39% | 12.94% | 10.92% | -0.38% |
| EPS Diluted | 7.90% | 18.42% | 15.22% | 11.48% | -0.38% |
| Normalized Diluted EPS | 13.00% | 16.18% | 12.72% | 10.84% | -0.19% |
| Average Basic Shares Outstanding | 0.40% | 0.40% | 0.41% | 0.50% | 0.53% |
| Average Diluted Shares Outstanding | 0.64% | 0.61% | 0.59% | 0.56% | 0.33% |
| Dividend Per Share | 13.33% | 13.33% | -- | 13.33% | -- |
| Payout Ratio | 0.03% | -0.03% | -0.76% | -- | -- |